Development and evaluation of extended-release vildagliptin tablets using quality by design
Background: Extended-release dosage forms are designed to enhance patient compliance and decrease dosing frequency. However, commercially available extended-release tablets are made with synthetic or semisynthetic controlled-release polymer, which causes a ghost pill effect. The ghost pill effect is...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Creative Pharma Assent,
2024-10-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |